Other
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
West Pharmaceutical Services Cash Provided by (Used in) Investing Activity, Including Discontinued Operation increased by 43.9% to -$42.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 40.1%, from -$71.30M to -$42.70M. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Investing Activity, Including Discontinued Operation shows a downward trend with a 3.1% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Reflects the overall net movement of cash into or out of the investment portfolio and capital assets.
Detailed definition
The total net cash flow from investing activities, aggregating both continuing and discontinued operations. It provides...
Peer comparison
Standard consolidated cash flow metric across all industries.
Metric ID:
other_net_cash_provided_by_used_in_investing_activitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$55.90M | -$65.30M | -$77.40M | -$68.30M | -$66.00M | -$59.10M | -$94.80M | -$82.10M | -$82.10M | -$95.70M | -$108.80M | -$90.60M | -$101.20M | -$82.10M | -$104.80M | -$71.30M | -$75.20M | -$63.30M | -$76.10M | -$42.70M |
| QoQ Change | — | -16.8% | -18.5% | +11.8% | +3.4% | +10.5% | -60.4% | +13.4% | +0.0% | -16.6% | -13.7% | +16.7% | -11.7% | +18.9% | -27.6% | +32.0% | -5.5% | +15.8% | -20.2% | +43.9% |
| YoY Change | — | — | — | — | -18.1% | +9.5% | -22.5% | -20.2% | -24.4% | -61.9% | -14.8% | -10.4% | -23.3% | +14.2% | +3.7% | +21.3% | +25.7% | +22.9% | +27.4% | +40.1% |
Range-$108.80M – -$42.70M
CAGR-5.5%
Avg YoY Growth-1.9%
Median YoY Growth-3.3%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's cash provided by (used in) investing activity, including discontinued operation?
- West Pharmaceutical Services (WST) reported cash provided by (used in) investing activity, including discontinued operation of -$42.70M in Q1 2026.
- How has West Pharmaceutical Services's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- West Pharmaceutical Services's cash provided by (used in) investing activity, including discontinued operation increased by 40.1% year-over-year, from -$71.30M to -$42.70M.
- What is the long-term trend for West Pharmaceutical Services's cash provided by (used in) investing activity, including discontinued operation?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's cash provided by (used in) investing activity, including discontinued operation has grown at a 3.1% compound annual growth rate (CAGR), from -$253.10M to -$285.90M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow from all investing activities, including both ongoing and discontinued operations.